Literature DB >> 2881974

Neuroleptic malignant syndrome.

J B Murray.   

Abstract

Neuroleptic Malignant Syndrome is a disabling reaction to neuroleptic drugs recently discussed in psychiatric literature in Europe, Japan, and the United States. It is rare but potentially fatal and is more likely to occur in men, especially young men, than in women. The cause is unknown, but dopamine depletion in the brain is suspected. Treatment usually begins by withdrawing the neuroleptics and then providing supportive therapy for the usual symptoms of high fever, muscular rigidity, labile blood pressure, and tachycardia. The Neuroleptic Malignant Syndrome usually lasts two to three weeks.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881974     DOI: 10.1080/00221309.1987.9711053

Source DB:  PubMed          Journal:  J Gen Psychol        ISSN: 0022-1309


  1 in total

1.  Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology.

Authors:  E M Jones; A Dawson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.